Literature DB >> 18086853

In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.

Klaudia Kosowska-Shick1, Catherine Clark, Kim Credito, Bonifacio Dewasse, Linda Beachel, Lois Ednie, Peter C Appelbaum.   

Abstract

When tested against nine strains of pneumococci and six of Haemophilus influenzae of various resistotypes, faropenem failed to select for resistant mutants after 50 days of consecutive subculture in subinhibitory concentrations. Faropenem also yielded low rates of spontaneous mutations against all organisms of both species. By comparison, resistant clones were obtained with macrolides, ketolides, and quinolones.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18086853      PMCID： PMC2224784          DOI： 10.1128/AAC.01389-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Pneumococcal vaccine--direct and indirect ("herd") effects.

Authors:  Daniel M Musher
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

2.  Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.

Authors:  Klaudia Kosowska-Shick; Kim L Credito; Glenn A Pankuch; Bonifacio DeWasse; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.

Authors:  Tatiana Bogdanovich; Catherine Clark; Lois Ednie; Gengrong Lin; Kathy Smith; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 4.  Redefining penems.

Authors:  Axel Dalhoff; Nebojsa Janjic; Roger Echols
Journal:  Biochem Pharmacol       Date:  2006-01-18       Impact factor: 5.858

5.  Activity of LBM415 compared to those of 11 other agents against Haemophilus species.

Authors:  Tatiana Bogdanovich; Kathy A Smith; Catherine Clark; Glenn A Pankuch; Gengrong Lin; Pamela McGhee; Bonifacio Dewasse; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 6.  Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.

Authors:  James A Hadley; Glenn S Tillotson; Robert Tosiello; Roger M Echols
Journal:  Expert Rev Anti Infect Ther       Date:  2006-12       Impact factor: 5.091

Review 7.  Faropenem: review of a new oral penem.

Authors:  Kristen N Schurek; Ryan Wiebe; James A Karlowsky; Ethan Rubinstein; Daryl J Hoban; George G Zhanel
Journal:  Expert Rev Anti Infect Ther       Date:  2007-04       Impact factor: 5.091

8.  Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.

Authors:  Klaudia Kosowska; Kim Credito; Glenn A Pankuch; Dianne Hoellman; Gengrong Lin; Catherine Clark; Bonifacio Dewasse; Pamela McGhee; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

9.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Authors:  Michael R Jacobs; David Felmingham; Peter C Appelbaum; Reuben N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2003-07-15       Impact factor: 5.790

10.  In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.

Authors:  Catherine Clark; Klaudia Kosowska; Bülent Bozdogan; Kim Credito; Bonifacio Dewasse; Pamela McGhee; Michael R Jacobs; Peter C Appelbaum
Journal:  Diagn Microbiol Infect Dis       Date:  2004-05       Impact factor: 2.803
View more
  4 in total

1.  Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.

Authors:  Ian A Critchley; Michael R Jacobs; Steven D Brown; Maria M Traczewski; Glenn S Tillotson; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

2.  Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.

Authors:  Catherine Clark; Pamela McGhee; Peter C Appelbaum; Klaudia Kosowska-Shick
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis.

Authors:  Hussein Chalhoub; Stefanie Kampmeier; Barbara C Kahl; Françoise Van Bambeke
Journal:  Front Microbiol       Date:  2022-03-28       Impact factor: 5.640

Review 4.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.